Menu Search
Equities

Teleflex Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
TBH:FRA

Teleflex Inc

Actions
  • Price (EUR)87.00
  • Today's Change-2.50 / -2.79%
  • Shares traded79.00
  • 1 Year change-45.28%
  • Beta0.8955
Data delayed at least 15 minutes, as of Feb 13 2026 07:05 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Teleflex Incorporated is a global provider of medical technologies. The Company offers a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. It primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. It operates in three segments: the Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). Its vascular access product portfolio includes Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous (bone access) systems. Its interventional product offerings consist of a portfolio of Arrow branded intra-aortic balloon pumps and catheters, GuideLiner, Turnpike and TrapLiner catheters, Pulsar-18 T3 Self-Expanding 4F Stent and Orsiro Mission Drug Eluting Stent.

  • Revenue in USD (TTM)3.19bn
  • Net income in USD-327.85m
  • Incorporated1943
  • Employees14.10k
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		TFX:NYQ since
announced		Transaction
value
BIOTRONIK GmbH & Co - Vascular Intervention businessDeal completed27 Feb 202527 Feb 2025Deal completed-40.67%796.71m
Data delayed at least 15 minutes, as of Feb 13 2026 18:27 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.